Personal information
Hauer, Julia Christina, Prof. Dr. med.
Department of Pediatrics
Pediatric Hematology and Oncology
University Hospital Carl Gustav Carus, TUD
Current position
Professor of Pediatric Hematology and Oncology (since 2019)
Head of Pediatric Hematology and Oncology
Role within partner site
Research on genetic predisposition and innate immunity in hemato-/ immuno-/- oncologic disease of childhood
Relevant work experience
Pediatric oncologist specialized in translational oncology
2019- Professor of Pediatric Hematology and Oncology, TUD
2019- Junior research group leader, NCT Dresden
2017-18 Professor of Experimental Pediatric Hematology and Oncology, Heinrich-Heine-Universität Düsseldorf
2014-18 Senior consultant, Heinrich-Heine-Universität Düsseldorf
2009-14 Physician-Scientist, Heinrich-Heine-Universität Düsseldorf
2006-09 Postdoctoral fellow, Hôpital Necker, Université René Descartes, Paris, France
2004-06 Clinical and research fellow, Ludwig-Maximilians-Universität Munich
Professional background
2015 Habilitation, Heinrich-Heine-Universität Düsseldorf
2006-09 Postdoctoral fellow
2006 MD Thesis, Ludwig-Maximilians-Universität Munich
Main research focus
Oncology, immunology, hematology
Publications
5 out of 36; SCOPUS h-index 14
Hauer J et al. Regional BCG vaccination policy in former East- and West Germany may impact on both severity of SARS-CoV-2 and incidence of childhood leukemia. Leukemia 2020;34:2217-9.
Rodriguez-Hernandez G, …, Hauer J et al. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID. Nat Commun 2019;10:5563.
Lin M, …, Hauer J, Auer F. JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility. Leukemia 2019;33:2331-5.
Bhatia S, …, Hauer J. Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response. Blood 2018;132:307-20.
Martin-Lorenzo A, Hauer J et al. Infection exposure is a causal factor in B-cell precursor acute lymphoblastic leukemia as a result of Pax5-inherited susceptibility. Cancer Discov 2015;5:1328-43.
Additional information
ERC starting grant (2019); Postdoctoral fellow scholarship, National Academy of Sciences Leopoldina
